Ignite Creation Date:
2025-12-24 @ 3:27 PM
Ignite Modification Date:
2026-01-07 @ 7:17 AM
Study NCT ID:
NCT02935192
Status:
COMPLETED
Last Update Posted:
2019-04-19
First Post:
2016-10-13
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Phase 3 Trial of Serbian Seasonal Influenza Vaccine
Sponsor:
Institute of Virology, Vaccines and Sera, Torlak
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
Torlak-300
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None